Christopher J. Coughlin, Director at Allergan plc (AGN), bought 18,583 shares at $190.59 ($3.5M) on 2018-09-06, disclosed to the SEC on 2018-09-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $190.55 | 1,300 | $248K | 7.0% |
| 2 | $190.55 | 1,300 | $248K | 7.0% |
| 3 | $190.56 | 705 | $134K | 3.8% |
| 4 | $190.56 | 705 | $134K | 3.8% |
| 5 | $190.57 | 27 | $5K | 0.1% |
| 6 | $190.58 | 100 |
| $19K |
| 0.5% |
| 7 | $190.59 | 356 | $68K | 1.9% |
| 8 | $190.59 | 356 | $68K | 1.9% |
| 9 | $190.60 | 400 | $76K | 2.2% |
| 10 | $190.61 | 200 | $38K | 1.1% |
| 11 | $190.62 | 68 | $13K | 0.4% |
| 12 | $190.63 | 300 | $57K | 1.6% |
| 13 | $190.64 | 517 | $99K | 2.8% |
| 14 | $190.64 | 517 | $99K | 2.8% |
| 15 | $190.65 | 100 | $19K | 0.5% |
| 16 | $190.66 | 816 | $156K | 4.4% |
| 17 | $190.66 | 816 | $156K | 4.4% |
| 18 | $190.67 | 222 | $42K | 1.2% |
| 19 | $190.68 | 4,889 | $932K | 26.3% |
| 20 | $190.68 | 4,889 | $932K | 26.3% |
| Total | $190.64 avg | 18,583 | $3.5M | 100% |
| Filing → |
| CNC | BUY | 2022-05-03 | $976K | — | Filing → |
| ALXN | BUY | 2018-05-02 | $1.2M | — | Filing → |
| AGN | BUY | 2017-12-05 | $1.6M | — | Filing → |